IL13 and asthma: reported that the intravascular administration of NOD1 or NOD2 ligands to mice subjected concomitantly to an OVA and alum asthma model induced significant increases in bronchoalveolar lavage (BAL) eosinophils, BAL levels of IL13, and seric total IgE (113).